Inventor
Zhen Li
Inventor
Monona, WI, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C12NMicroorganisms or enzymes19%
A61KPreparations for medical, dental or toiletry purposes17%
C07DHeterocyclic compounds8%
C07HSugars8%
C07CAcyclic or carbocyclic compounds4%
C12YEnzymes4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
D0923042Display screen with transitional graphical user interface202110,822,416Anti-PD-L1 antibodies202010,780,108RNAi agents for Hepatitis B virus infection202010,662,427Compositions and methods for inhibiting gene expression of LPA202010,597,657RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)202010,590,416RNAi agents for inhibiting expression of alpha-ENaC and methods of use202010,450,565Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use201910,294,474Targeting ligands201910,246,709Targeting ligands for therapeutic compounds20199,932,586Compositions and methods for inhibiting gene expression of LPA20187,879,875'P38 kinase inhibiting agents'20117,351,725'N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists'20087,199,142'1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists'20076,329,393'Crystalline pharmaceutically acceptable salts of an oxazolidinone derivative'20016,201,115'Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications'20016,201,158'Process for making intermediate aldehydes'20015,914,395'Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2001Patents assigned to PASTEUR INSTITUT (2)· patent assignee history
1999–2001Patents assigned to UNIV PARIS 7 (2)· patent assignee history
1999–2001Based in Paris, FR· patent location history
2001–2008Patents assigned to MERCK & CO INC (4)· patent assignee history
2001–2011Based in Scotch Plains, NJ, US· patent location history
2018–2020Patents assigned to ARROWHEAD PHARMACEUTICALS INC (8)· patent assignee history
2018–2020Based in Monona, WI, US· patent location history
2020Based in Suzhou, CN· patent location history
2021Patents assigned to FOURTH PARADIGM BEIJING TECH CO LTD (1)· patent assignee history
2021Based in Beijing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS INC | 8 | 2018–2020 |
| MERCK & CO INC | 4 | 2001–2008 |
| PASTEUR INSTITUT | 2 | 1999–2001 |
| UNIV PARIS 7 | 2 | 1999–2001 |
| FOURTH PARADIGM BEIJING TECH CO LTD | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Monona, WI, US | 7 | 2018–2020 |
| Scotch Plains, New Jersey, US | 5 | 2001–2011 |
| Paris, FR | 2 | 1999–2001 |
| Beijing, CN | 1 | 2021 |
| Suzhou, CN | 1 | 2020 |